Maryland Oncology Hematology, P.A.

7704 Matapeake Business Drive
Brandywine, Maryland 20613

We've found

1 trials

at this facility

ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Brandywine, MD

Use our guide to learn which trials are right for you!